Biddy Fraga

Representation of REE Automotive Ltd., an electric-vehicle technology start-up based in Israel, in its US$3.6 billion go-public acquisition by 10X Capital Venture Acquisition Corp. (Nasdaq: VCVCU), a SPAC.

Representation of ION Acquisition Corp 2 Ltd. (NYSE: IACB), a SPAC, in its $253.0 million initial public offering and listing on the NYSE.

Representation of Guggenheim Securities, LLC as representative of the underwriters in connection with the US$45 million follow-on offering for SCYNEXIS, Inc. (Nasdaq: SCYX), a biotechnology company pioneering innovative medicines to help millions of patients worldwide overcome and prevent difficult-to-treat infections that are becoming increasingly drug-resistant.

Representation of Credit Suisse Securities (USA) LLC and Morgan Stanley & Co. LLC as bookrunners and initial purchasers on Cano Health, LLC's inaugural high yield debt issuance. The company, one of the largest independent primary care physician groups in the United States, issued US$300 million of 6.250% senior notes due 2028.

Representation of Jefferies LLC and Stephens Inc. as initial purchasers in CURO Finance LLC's, a wholly-owned subsidiary of CURO Group Holdings Corp., offering of $250 million aggregate principal amount of 7.500% senior secured notes due 2028. CURO is a technology-enabled, multi-channel and multi-product consumer finance company serving a wide range of non-prime and prime consumers in the U.S. and Canada.

Representation of Stone Point Capital LLC, as sponsor, and Alliant Holdings Intermediate, LLC and Alliant Holdings Co-Issuer, Inc., as issuers, on their offering of (i) US$225 million aggregate principal amount of additional 4.250% senior secured notes due 2027 and (ii) US$450 million aggregate principal amount of 5.875% senior notes due 2029.